Clinical Appraisal of TURP in Gezira Hospital for Renal Diseases and Surgery

Elssayed Osman Elssayed

Authors

Elssayed Osman Elssayed

Keywords:

turp, ghrds, bph

Abstract

Transurethral resection of the prostate(TURP) is the gold standard for the surgical treatment of benign prostatic hyperplasia(BPH)-related lower urinary tract symptoms (LUTS). Objective : The main goal is to evaluate patients selection the complications and the outcome following TURP in (Gezira hospital for renal diseases and surgery) GHRDS. Methodology : This study was a prospective, hospital based, small scale study conducted in the period between January 2012 to June 2013 in Gezira Hospital for Renal Diseases and Surgery. Ninety four patients underwent TURP for (benign prostatic hyperplasia) BPH were included in this study. The management was done according to the European association of urological surgeons (EAU) guideline for the indication of surgery, procedure and postoperative treatment.The data was collected in a form of data sheet (patient's records, direct interviews and a pre-designed questionnaire). Data coded and fed in computer to handle statistical and mathematical procedure, using SPSS 17(statistical package for social sciences). Result : One hundred and thirty two patients were enrolled, twenty one patients were excluded due tunneling TURP for Ca prostate and 17 had incomplete follow up or record. Mean age of (69.02) years, mean hospital stay (1.5) days, mean follow-up of (7.19) month and mean operation time was (39.9) minute. Fortunately no mortality stated with significant improvement in international prostate symptoms score ( IPSS) on the long term (87.2%) and minimal complication like perforation occur in 2 patients (2.1%), while 1 patient (1.1%) develop bleeding. Conclusion : The outcome of TURP in GHRDS is good with minimum intraoperative and postoperative complications.

Downloads

How to Cite

Clinical Appraisal of TURP in Gezira Hospital for Renal Diseases and Surgery. (2013). Global Journal of Medical Research, 13(I3), 13-17. https://medicalresearchjournal.org/index.php/GJMR/article/view/398

Download Citation

References

Emil Tanagho, J Ed (2008) neoplasm of prostate gland.

J Nickel, C Méndez-Probst, T Whelan (2010) the Canadian Prostate Health Council and the CUA Guidelines Committee 2010 Update: Guidelines for the management of benign prostatic hyperplasia. 4, 310-316.

C Roehrborn, J Mcconnell, M Barry (2010) AUA Guideline on the management of benign prostatic hyperplasia.

Jean De La Rosette, Gerasimos Alivizatos, Stephan Madersbacher, Massimo Perachino, David Thomas, FrançOis Desgrandchamps, Michel De Wildt (2006) EAU Guidelines on Benign Prostatic Hyperplasia (BPH). 40(3), 256-263.

S Madersbacher, G Alivizatos, J Nordling, C Sanz, M Emberton, Jjmch De La Rosette (2004) EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). 46, 547-554.

J Wilson, G Urwin, M Stower (2004) The changing practice of transurethral prostatectomy: a comparison of cases performed in 1990 and 2000. 86(6), 428-431.

Alan Wein, L Andrew, C Novick, Alan Partin, Craig Peters, Ed (2007) Minimally invasive and edoscopic management og beingn prostatic hyperplasia.

M Agarwal, J Palmer, G Mufti (1993) Transurethral resection for a large prostate--is it safe?. 72(3), 318-321.

Giovanni Muzzonigro, Giulio Milanese, Daniele Minardi, Mammoud Yehia, Andrea Galosi, Marco Dellabella (2004) SAFETY AND EFFICACY OF TRANSURETHRAL RESECTION OF PROSTATE GLANDS UP TO 150 ML: A PROSPECTIVE COMPARATIVE STUDY WITH 1 YEAR OF FOLLOWUP. 172(2), 611-615.

X Yu, S Elliott, T Wilt (2008) Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. 180, 241-245.

Norman Williams, C, P Ronan O'connell, Ed (2008) The prostate and seminal vesicles. Bailey & Love's SHORT PRACTICE of SURGERY.

Jens Rassweiler, Dogu Teber, Rainer Kuntz, Rainer Hofmann (2006) Complications of Transurethral Resection of the Prostate (TURP)-Incidence, Management, and Prevention. 50(5), 969-980.

Oliver Reich, Christian Gratzke, Alexander Bachmann, Michael Seitz, Boris Schlenker, Peter Hermanek, Nicholas Lack, Christian Stief (2008) Morbidity, Mortality and Early Outcome of Transurethral Resection of the Prostate: A Prospective Multicenter Evaluation of 10,654 Patients. 180(1), 246-249.

S Ahyai, P Gilling, S Kaplan (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. 58, 384-397.

Robert Hahn (2001) SMOKING INCREASES THE RISK OF LARGE SCALE FLUID ABSORPTION DURING TRANSURETHRAL PROSTATIC RESECTION. 166(1), 162-165.

A Tascı, Y Ilbey, V Tugcu, O Cicekler, C Cevik, F Zoroglu (2011) Transurethral resection of the prostate with monopolar resectoscope: single-surgeon experience and long-term results of after 3589 procedures. 78(5), 1151-1155.

Antonio Pastore, Simone Mariani, Francesco Barrese, Giovanni Palleschi, Armando Valentini, Luca Pacini, Vincenzo Petrozza, Antonio Carbone, Manlio Cappa (2013) Transurethral Resection of Prostate and the Role of Pharmacological Treatment with Dutasteride in Decreasing Surgical Blood Loss. 27(1), 68-70.

J Donohue, H Sharma, R Abraham (2002) Transurethral prostate resection and bleeding: a randomised, placebo controlled trial of the role of finasteride for decreasing operative blood loss. 168(5), 2024-2026.

Rainer Hofmann, Achim Elert, Sebastian Wille (2005) Transurethrale Resektion (TURP) und transurethrale Inzision (TUIP) der Prostata. 49-84.

R Hartung, H Leyh (2002) Die transurethrale Elektroresektion der Prostata (TURP). 36(3), 255-270.

P Faul (1993) Video TUR: Raising the Gold Standard. 24(2), 256-261.

F Kallenberg, T Hossack, H Woo (2011) Long-Term Followup after Electrocautery Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia. 2011, 1-6.

Jeng-Sheng Chen, Chia-Hsien Chang, Wen-Horng Yang, Yea-Huei Kao (2012) Acute urinary retention increases the risk of complications after transurethral resection of the prostate. 110(11), 896-E901.